Published date: 26 January 2018

Last edited date: 26 January 2018

This notice was replaced on 26 January 2018

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Future opportunity (published 26 January 2018)

Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.


Contract summary

Industry

  • Blood products - 33141510

Location of contract

Any region

Value of contract

£4,000,000

Procurement reference

CM/PHS/17/5552

Published date

26 January 2018

Approach to market date

1 February 2018

Contract start date

1 July 2018

Contract end date

30 June 2019

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

NHS National Framework Agreement for Factor X and Porcine Factor VIII

More information

Spend profile

This table displays the spend profile of the notice
Financial year Budget
2018/2019 £3,000,000
2019/2020 £1,000,000

Additional text

The product outlined in this future opportunity notice has been incorporated into the OPEN current future opportunity notice for 'Bleeding Disorders' (CM/PHS/15/5499) - hence this notice has been withdrawn.

About the buyer

Address

Commercial Medicines Unit
2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

alison.greenwood3@nhs.net